GlaxoSmithKline
GSK
$44.15
Share price
1.61%
Change (1 day)
20.07%
Change (1 year)
Categories
Market capitalization of GlaxoSmithKline (GSK)
Market cap: $90.07 Billion
As of May 2024 GlaxoSmithKline has a market cap of $90.07 Billion. This makes GlaxoSmithKline the world's 177th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of GlaxoSmithKline from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $90.07 B | 18.13% |
| 2023 | $76.25 B | 6% |
| 2022 | $71.93 B | -34.07% |
| 2021 | $109.10 B | 18.9% |
| 2020 | $91.76 B | -21.15% |
| 2019 | $116.38 B | 23.9% |
| 2018 | $93.93 B | 6.6% |
| 2017 | $88.11 B | -6.48% |
| 2016 | $94.22 B | -4.88% |
| 2015 | $99.05 B | -4.91% |
| 2014 | $104.16 B | -19.26% |
| 2013 | $129.00 B | 21.97% |
| 2012 | $105.76 B | -8.18% |
| 2011 | $115.19 B | 13.05% |
| 2010 | $101.89 B | -7.08% |
| 2009 | $109.65 B | 13.45% |
| 2008 | $96.66 B | -30.35% |
| 2007 | $138.78 B | -8.6% |
| 2006 | $151.83 B | 3.03% |
| 2005 | $147.36 B | 4.74% |
| 2004 | $140.69 B | 6.84% |
| 2003 | $131.68 B | 16.71% |
| 2002 | $112.83 B | -26.62% |
| 2001 | $153.76 B |
End of Day market cap according to different sources
On May 6th, 2024 the market cap of GlaxoSmithKline was reported to be:
$88.59 Billion
$88.59 Billion
$90.04 Billion
$89.47 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $202.14 B | 124.41% | 🇨🇭 Switzerland |
 Pfizer PFE | $157.24 B | 74.57% | 🇺🇸 USA |
 Sanofi SNY | $123.74 B | 37.38% | 🇫🇷 France |
 Merck MRK | $330.22 B | 266.60% | 🇺🇸 USA |
 AstraZeneca AZN | $236.62 B | 162.69% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $15.80 B | -82.46% | 🇮🇱 Israel |
 Dynavax Technologies
DVAX | $1.53 B | -98.29% | 🇺🇸 USA |